Birmingham, AL5 Active Studies

Substance Use Disorder Clinical Trials in Birmingham, AL

Find 5 actively recruiting substance use disorder clinical trials in Birmingham, AL. Connect with local research sites and explore new treatment options.

5
Active Trials
2
Sponsors
1,625
Enrolling

Recruiting Substance Use Disorder Studies in Birmingham

About Substance Use Disorder Clinical Trials in Birmingham

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 5 substance use disorder clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 1,625 participants. Research is being sponsored by Eli Lilly and Company, University of Alabama at Birmingham. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Birmingham — FAQ

Are there substance use disorder clinical trials in Birmingham?

Yes, there are 5 substance use disorder clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 5 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated July 13, 2026 from ClinicalTrials.gov